Sign Out
Pregnancy: Based on the wide experience with this drug and its chemical structure and pharmacological properties, it is not expected to present a risk of foetal abnormalities when used as indicated (for induction or augmentation of labour).
One study has shown that treatment of rats with oxytocin in early pregnancy at doses considered sufficiently in excess of the maximum recommended human dose caused embryonic loss. No standard reproductive performance studies with oxytocin are available.
Breastfeeding: Oxytocin may be found in small quantities in mother's breast milk. However, oxytocin is not expected to cause harmful effects in the newborn, because it passes into the alimentary tract where it undergoes rapid inactivation.
Females and males of reproductive potential: Not applicable for Oxytocin-Richter because of the targeted indications.
Infertility: Not applicable for Oxytocin-Richter because of the targeted indications.
Continue with Google